Crescent Biopharma (CBIO) Net Equity Issued and Repurchased (2014 - 2026)
Crescent Biopharma's Net Equity Issued and Repurchased was $280,000 in Q2 2026.
Powered by 
Analysis
Crescent Biopharma (CBIO) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Crescent Biopharma's Net Equity Issued and Repurchased was $179.16 million through Jun 30, 2026; for FY2025, it came in at $178.88 million.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 58.6% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $5,398 in FY2024 (-100.0%), $28.71 million in FY2023 (+590.5%), $4.16 million in FY2022 (-61.1%) and $10.7 million in FY2021 (-40.0%).
- The Q2 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Crescent Biopharma | 404.96 Mn | -302.33 Mn | - | 280,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 280,000.00 |
| Dec 31, 2025 | 178.88 Mn |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 4.00 Mn |
| Jun 30, 2024 | 500.00 |
| Mar 31, 2024 | 4,898.00 |
| Mar 31, 2023 | 28.71 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Mar 31, 2021 | 9.56 Mn |
| Dec 31, 2020 | 3.71 Mn |
| Sep 30, 2020 | 4.55 Mn |
| Jun 30, 2020 | 9.44 Mn |
| Mar 31, 2020 | 129,972.00 |
| Dec 31, 2019 | 119,822.00 |
| Sep 30, 2019 | 186,770.00 |
| Jun 30, 2019 | 75,767.00 |
| Mar 31, 2019 | 30,554.00 |
| Jun 30, 2018 | -208,920.00 |
| Mar 31, 2018 | 128.63 Mn |
| Dec 31, 2017 | 19.30 Mn |
API Access
Crescent Biopharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();